البحث | SocioMint

Rutuja Bhosale أضاف وظيفة جديدة أخرى
2026-08-12 07:32:00 -

Dopamine Agonist Market Analysis: Investment, Innovation, and Growth Opportunities Through 2034
The Global Dopamine Agonist Market is experiencing steady growth, driven by the rising prevalence of neurological and hormonal disorders and the increasing demand for effective pharmacological treatments. Valued at approximately USD 1.6 billion in 2025, the market is projected to reach USD 2.5 billion by 2033, expanding at a CAGR of 6.1% during the forecast...

0 التعليقات 0 المشاركات 25 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Surbhi Verma أضاف وظيفة جديدة Health
2026-07-02 10:32:51 -

Prolactinoma Market: How Is Cabergoline Resistance and Dopamine Agonist-Intolerant Patient Management Creating New Therapeutic Opportunities?
Prolactinoma — the benign pituitary adenoma arising from lactotroph cells causing hyperprolactinemia, galactorrhea, amenorrhea, infertility, and mass effect symptoms including headache and visual field defects — represents the most common functioning pituitary tumor requiring chronic pharmacological management, with the Prolactinoma Market reflecting dopamine agonist therapy and...

0 التعليقات 0 المشاركات 621 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!

SocioMint https://sociomint.com